Terazosin how supplied
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
How supplied
Overview
1 mg
2 mg
5 mg
10 mg
Moisture/light
Dispensing
Storage
Overview
Terazosin Hydrochloride Capsules, 1 mg, 2 mg, 5 mg and 10 mg contain 1 mg, 2 mg, 5 mg or 10 mg of Terazosin as Terazosin hydrochloride anhydrous, respectively. Return to top
1 mg
The 1 mg capsule has a rich yellow opaque cap and a light lavender opaque body. The capsule is axially imprinted with MYLAN over 2260 in black ink on both the cap and body. They are available as follows:
- NDC 0378-2260-01 (bottles of 100 capsules)
- NDC 0378-2260-10 (bottles of 1000 capsules)
2 mg
The 2 mg capsule has a black opaque cap and a light lavender opaque body. The capsule is axially imprinted with MYLAN over 2264 in white ink on both the cap and body. They are available as follows:
- NDC 0378-2264-01 (bottles of 100 capsules)
- NDC 0378-2264-10 (bottles of 1000 capsules)
5 mg
The 5 mg capsule has a iron gray opaque cap and a light lavender opaque body. The capsule is axially imprinted with MYLAN over 2268 in black ink on both the cap and body. They are available as follows:
- NDC 0378-2268-01 (bottles of 100 capsules)
- NDC 0378-2268-10 (bottles of 1000 capsules)
10 mg
The 10 mg capsule has a light lavender opaque cap and a light lavender opaque body. The capsule is axially imprinted with MYLAN over 1570 in black ink on both the cap and body. They are available as follows:
- NDC 0378-1570-01 (bottles of 100 capsules)
- NDC 0378-1570-10 (bottles of 1000 capsules)
Moisture/light
PROTECT FROM LIGHT AND MOISTURE. Return to top
Dispensing
Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Return to top
Storage
STORE AT CONTROLLED ROOM TEMPERATURE 15° to 30°C (59° to 86°F). Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
